NEW YORK (GenomeWeb News) - Nanosphere yesterday said third-quarter revenues fell 58 percent as R&D spending rose 37 percent and its net loss ballooned.
 
Total receipts for the three months ended Sept. 30 decreased to $199,000 from $468,500 year over year.
 
The company said product-related revenue fell to $6,125 from $89,030, and grant and contract revenue fell to $192,880 from $379,494.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.